Mark V. Rubertone

4.8k citations
39 papers · 3.4k · 1 hit paper · h-index 22

Impact in

  • Rheumatology top 0.5%
    • Systemic Lupus Erythematosus Research
    • Rheumatoid Arthritis Research and Therapies
  • Immunology top 2%
    • T-cell and B-cell Immunology
    • Immune Cell Function and Interaction
    • Atherosclerosis and Cardiovascular Diseases

Papers in

Mark V. Rubertone

39 papers receiving 3.3k citations

Mark V. Rubertone's Hit Papers

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus 2003 · 1.8k citations
1.8k0+7+15Years since publication50010001.5k

Peers

Mark V. Rubertone
Comparison fields: 5 of 123
  • Rheumatology 1.7k
  • Immunology 1.3k
  • Radiology, Nuclear Medicine and Imaging 770
  • Occupational Therapy 94
  • Pathology and Forensic Medicine 406
Replace Nádia Emi Aikawa with:
Nádia Emi Aikawa Brazil
Monika Østensen Norway
Jeffrey P. Callen United States
Mutlu Hayran Türkiye
Elena Massarotti United States
Michele F. Doran Ireland
O. Fain France
Debra S. Heller United States
Alessandro Caruso Italy
Alessandra Vultaggio Italy
Mark V. Rubertone relative to Nádia Emi Aikawa Brazil Nádia Emi Aikawa's profile →
Citations per field
00.5×4.5×
Nádia Emi Aikawa · 1×
Citations per year

Countries citing papers authored by Mark V. Rubertone

Since Specialization
Citations

This map shows the geographic impact of Mark V. Rubertone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark V. Rubertone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark V. Rubertone more than expected).

Fields of papers citing papers by Mark V. Rubertone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark V. Rubertone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark V. Rubertone. The network helps show where Mark V. Rubertone may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark V. Rubertone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark V. Rubertone Line = papers co-authored together Mark V. Rubertone links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Hit paper breakdown →
20031814
2 2002253
3 2007146
4 2008142
5 2004127
6 200196
7 200361
8 200650
9 200347
10 200845
11 200744
12 200942
13 200039
14 201537
15 199637
16 200336
17 201233
18 200431
19 201530
20 200929

About Mark V. Rubertone

Mark V. Rubertone is a scholar working on Surgery, Molecular Biology, Rheumatology, Reproductive Medicine and Infectious Diseases, having authored 39 papers that have together received 3.4k indexed citations. Recurring topics across this work include Testicular diseases and treatments (13 papers), Sexual Differentiation and Disorders (9 papers), Sperm and Testicular Function (7 papers), Systemic Lupus Erythematosus Research (5 papers), Hepatitis B Virus Studies (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Rheumatology (1.7k citations), Immunology (1.3k citations), Radiology, Nuclear Medicine and Imaging (770 citations), Occupational Therapy (94 citations) and Pathology and Forensic Medicine (406 citations). Mark V. Rubertone has collaborated with scholars based in United States and Canada. Frequent co-authors include Judith A. James, John B. Harley, Melissa R. Arbuckle, G. Dennis, Micah T. McClain, R. Hal Scofield, John F. Brundage, Katherine A. McGlynn, Barry I. Graubard and Ralph L. Erickson. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, Vaccine, American Journal of Epidemiology, International Journal of Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact